Skip to main content
Erschienen in: Endocrine 2/2020

18.11.2019 | Original Article

A randomized trial comparing health-related quality-of-life and utility measures between routine fine-needle aspiration cytology (FNAC) and surveillance alone in patients with thyroid incidentaloma measuring 1–2 cm

verfasst von: Carlos K. H. Wong, Brian H. H. Lang

Erschienen in: Endocrine | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To present the impact of treatment on health-related quality-of-life (HRQOL) and health utility measures from the randomized controlled trial (ClinicalTrials.gov Identifier: NCT02398721) that investigated the FNAC versus watchful surveillance in patients with incidental benign thyroid nodules.

Methods

Health utility and HRQOL were evaluated using the EQ-5D 5-level (EQ-5D-5L), 6-item Short-Form Health Survey (SF-6D), and generic 12-item Short-Form Health Survey (SF-12v2) at baseline, 3-month, 6-month, and 12-month assessments. A repeated measure analysis of variance evaluated differences in HRQOL scores between treatment groups over time. Multiple imputations were used to impute missing data at each time point.

Results

HRQOL data completion rates were 99.7% at baseline, 92.7% at 3-month, 93.9% at 6-month, 92.7% at 12-month, and 88.6% at 18-month follow-up after baseline. There were significant mean differences in SF-6D, EQ-5D-5L, and SF-12v2 over time except the domain of vitality and mental health of SF-12v2. Mean change of SF-12v2 scores and utility scores from baseline between groups did not exceed minimal important difference. No significant treatment group by time interactions were found in all HRQOL and utility scores except in the vitality domain and PCS of SF-12v2 (p value = 0.033; 0.024).

Conclusions

When compared with watchful surveillance, FNAC intervention was associated with better vitality and physical-related HRQOL scores but did not provide better preservation of utility score improvement over the 18-month period. These findings support the routine FNAC approach for nodules that have a low-suspicion sonographic pattern and measure between 1.0 and 2.0 cm.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat S. Ezzat et al. Thyroid incidentalomas: prevalence by palpation and ultrasonography. Arch. Intern. Med. 154(16), 1838–1840 (1994)CrossRef S. Ezzat et al. Thyroid incidentalomas: prevalence by palpation and ultrasonography. Arch. Intern. Med. 154(16), 1838–1840 (1994)CrossRef
2.
Zurück zum Zitat D.S. Dean, H. Gharib, Epidemiology of thyroid nodules. Best. Pract. Res. Clin. Endocrinol. Metab. 22(6), 901–911 (2008)CrossRef D.S. Dean, H. Gharib, Epidemiology of thyroid nodules. Best. Pract. Res. Clin. Endocrinol. Metab. 22(6), 901–911 (2008)CrossRef
3.
Zurück zum Zitat D.S. Ross, Nonpalpable thyroid nodules–managing an epidemic. J. Clin. Endocrinol. Metab. 87(5), 1938–1940 (2002)PubMed D.S. Ross, Nonpalpable thyroid nodules–managing an epidemic. J. Clin. Endocrinol. Metab. 87(5), 1938–1940 (2002)PubMed
4.
Zurück zum Zitat G. Russ, Risk stratification of thyroid nodules on ultrasonography with the French TI-RADS: description and reflections. Ultrasonography 35(1), 25–38 (2016)CrossRef G. Russ, Risk stratification of thyroid nodules on ultrasonography with the French TI-RADS: description and reflections. Ultrasonography 35(1), 25–38 (2016)CrossRef
5.
Zurück zum Zitat S. Leboulleux et al. Frequency and intensity of pain related to thyroid nodule fine-needle aspiration cytology. Thyroid 23(9), 1113–1118 (2013)CrossRef S. Leboulleux et al. Frequency and intensity of pain related to thyroid nodule fine-needle aspiration cytology. Thyroid 23(9), 1113–1118 (2013)CrossRef
6.
Zurück zum Zitat B.R. Haugen et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1–133 (2016)CrossRef B.R. Haugen et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1–133 (2016)CrossRef
7.
Zurück zum Zitat L. Lodewijk et al. Same-day fine-needle aspiration cytology diagnosis for thyroid nodules achieves rapid anxiety decrease and high diagnostic accuracy. Endocr. Pract. 22(5), 561–566 (2016)CrossRef L. Lodewijk et al. Same-day fine-needle aspiration cytology diagnosis for thyroid nodules achieves rapid anxiety decrease and high diagnostic accuracy. Endocr. Pract. 22(5), 561–566 (2016)CrossRef
8.
Zurück zum Zitat C.K.H. Wong et al. EQ-5D-5L and SF-6D utility measures in symptomatic benign thyroid nodules: acceptability and psychometric evaluation. Patient 10(4), 447–454 (2017)CrossRef C.K.H. Wong et al. EQ-5D-5L and SF-6D utility measures in symptomatic benign thyroid nodules: acceptability and psychometric evaluation. Patient 10(4), 447–454 (2017)CrossRef
9.
Zurück zum Zitat P. Wang et al. The EQ-5D-5L is more discriminative than the EQ-5D-3L in patients with diabetes in Singapore. Value Health Reg. Issues 9, 57–62 (2016)CrossRef P. Wang et al. The EQ-5D-5L is more discriminative than the EQ-5D-3L in patients with diabetes in Singapore. Value Health Reg. Issues 9, 57–62 (2016)CrossRef
10.
Zurück zum Zitat P.W.H. Cheung et al. Psychometric validation of the EuroQoL 5-Dimension 5-Level (EQ-5D-5L) in Chinese patients with adolescent idiopathic scoliosis. Scoliosis Spinal Disord. 11, 19 (2016)CrossRef P.W.H. Cheung et al. Psychometric validation of the EuroQoL 5-Dimension 5-Level (EQ-5D-5L) in Chinese patients with adolescent idiopathic scoliosis. Scoliosis Spinal Disord. 11, 19 (2016)CrossRef
11.
Zurück zum Zitat C.-W. Pan et al. Valuing health-related quality of life in type 2 diabetes patients in China. Med. Decis. Mak. 36(2), 234–241 (2016)CrossRef C.-W. Pan et al. Valuing health-related quality of life in type 2 diabetes patients in China. Med. Decis. Mak. 36(2), 234–241 (2016)CrossRef
12.
Zurück zum Zitat B. van Hout et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 15(5), 708–715 (2012)CrossRef B. van Hout et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 15(5), 708–715 (2012)CrossRef
13.
Zurück zum Zitat G.G. Liu et al. Chinese time trade-off values for EQ-5D health states. Value Health 17(5), 597–604 (2014)CrossRef G.G. Liu et al. Chinese time trade-off values for EQ-5D health states. Value Health 17(5), 597–604 (2014)CrossRef
14.
Zurück zum Zitat N.S. McClure et al. Instrument-defined estimates of the minimally important difference for EQ-5D-5L index scores. Value Health 20(4), 644–650 (2017)CrossRef N.S. McClure et al. Instrument-defined estimates of the minimally important difference for EQ-5D-5L index scores. Value Health 20(4), 644–650 (2017)CrossRef
15.
Zurück zum Zitat J.E. Brazier, J. Roberts, The estimation of a preference-based measure of health from the SF-12. Med. Care 42(9), 851–859 (2004)CrossRef J.E. Brazier, J. Roberts, The estimation of a preference-based measure of health from the SF-12. Med. Care 42(9), 851–859 (2004)CrossRef
16.
Zurück zum Zitat C.L.K. Lam, J. Brazier, S.M. McGhee, Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a chinese population. Value Health 11(2), 295–303 (2008)CrossRef C.L.K. Lam, J. Brazier, S.M. McGhee, Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a chinese population. Value Health 11(2), 295–303 (2008)CrossRef
17.
Zurück zum Zitat S.M. McGhee et al. Quality-adjusted life years: population-specific measurement of the quality component. Hong. Kong Med. J. 17(Suppl 6), 17–21 (2011)PubMed S.M. McGhee et al. Quality-adjusted life years: population-specific measurement of the quality component. Hong. Kong Med. J. 17(Suppl 6), 17–21 (2011)PubMed
18.
Zurück zum Zitat S.J. Walters, J.E. Brazier, Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual. Life Res. 14(6), 1523–1532 (2005)CrossRef S.J. Walters, J.E. Brazier, Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual. Life Res. 14(6), 1523–1532 (2005)CrossRef
19.
Zurück zum Zitat C.K. Wong, E.T. Lam, C.L. Lam, Comparison of direct-measured and derived short form six dimensions (SF-6D) health preference values among chronic hepatitis B patients. Qual. Life Res. 22(10), 2973–2981 (2013)CrossRef C.K. Wong, E.T. Lam, C.L. Lam, Comparison of direct-measured and derived short form six dimensions (SF-6D) health preference values among chronic hepatitis B patients. Qual. Life Res. 22(10), 2973–2981 (2013)CrossRef
Metadaten
Titel
A randomized trial comparing health-related quality-of-life and utility measures between routine fine-needle aspiration cytology (FNAC) and surveillance alone in patients with thyroid incidentaloma measuring 1–2 cm
verfasst von
Carlos K. H. Wong
Brian H. H. Lang
Publikationsdatum
18.11.2019
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2020
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-02129-y

Weitere Artikel der Ausgabe 2/2020

Endocrine 2/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.